Uoto K, Ohsuki S, Takenoshita H, Ishiyama T, Iimura S, Hirota Y, Mitsui I, Terasawa H, Soga T
New Product Research Laboratories IV, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Chem Pharm Bull (Tokyo). 1997 Nov;45(11):1793-804. doi: 10.1248/cpb.45.1793.
To investigate the role of the 2'-hydroxy group at the C-13 side chain of docetaxel in the antitumor activity, we prepared several 2',2'-difluoro derivatives of docetaxel and evaluated their cytotoxicity against mouse leukemia and human tumor cell lines and their microtubule disassembly-inhibitory activity. These analogues were prepared by esterification of protected 10-deacetylbaccatin III (21) with appropriate alpha, alpha-difluorinated carboxylic acids (Charts 1 and 2). Among these 2',2'-difluorodocetaxel derivatives, 2',2'-difluorodocetaxel (23b) was approximately 3-10 times as active as 2'-fluorodocetaxel (29a) in terms of cytotoxicity. In addition, the 3'-(2-furyl) (23h) and 3'-(2-pyrrolyl) (23p) analogues showed activity comparable or superior to that of docetaxel (2).
为了研究多西他赛C-13侧链上2'-羟基在抗肿瘤活性中的作用,我们制备了几种多西他赛的2',2'-二氟衍生物,并评估了它们对小鼠白血病和人肿瘤细胞系的细胞毒性以及它们的微管解聚抑制活性。这些类似物是通过用适当的α,α-二氟羧酸对保护的10-去乙酰浆果赤霉素III(21)进行酯化反应制备的(图1和图2)。在这些2',2'-二氟多西他赛衍生物中,就细胞毒性而言,2',2'-二氟多西他赛(23b)的活性约为2'-氟多西他赛(29a)的3至10倍。此外,3'-(2-呋喃基)(23h)和3'-(2-吡咯基)(23p)类似物显示出与多西他赛(2)相当或优于多西他赛的活性。